Laboratory of Experimental Virology
Publications
14
Citations
99
h-index
6
Authorization required.
- Immunohistochemistry (IHC)
- Immunocytochemistry
- Methods for assessing the viability and growth of cell and tissue cultures
- Assessment of cytotoxic activity (MTT test, Cell-TitreGlo, Rezazurin, Cell/Death kit)
- Working with laboratory animals
- Classical virological methods
- Virus isolation and identification
- Determination of pathogenicity
- Evaluation of infectious titers
- Setting up models of experimental oncogenesis
- Tumor models in vivo: syngenic models, xenografts
Kseniya Yurchenko
Head of Laboratory
Marina Gulyaeva
Senior Researcher
Yuri Karkavin
Engineer
Lyubov Adamenko
Junior researcher
Alexandra Glushchenko
Junior researcher
Veronika Kovalenko
Research assistant
Research directions
Primal screening of oncolytic properties of wild-type Newcastle disease virus strains
+
- evaluation of biological qualities of wild-type viral isolates by classical virological methods
- cytotoxic properties testing on a panel of secondary human and animal tumor cells
Study of virus-mediated mechanisms of tumor cell death
+
- research for new effective oncolytic strains and evaluation of antitumor activity on human tumor cell lines in vitro and in vivo models
- study of the molecular antitumor oncolytic mechanisms - the direct cytotoxic antitumor effect of viral strains and the indirect immunostimulating effect depending on the method of virus administration, infectious dose, treatment scheme and other parameters of virotherapy
- evaluation of the correlation between the effectiveness of antitumor virotherapy, virus-mediated activation of the immune system, activation scheme of tumor cell death and toxicological characteristics of the studied Newcastle disease virus strains
Search and development of a laboratory sample of a drug for oncolytic virotherapy based on a virus with the most pronounced antitumor properties
+
- development of methodological solutions related to the optimization of the viral strains cultivation, its preparation for dosage form, related to the choice of storage conditions and the composition of solutions, culture media and other necessary components
- development process of the viral substance while maintaining a high antitumor potential, safety for mammals and stability of the genetic material during manipulations for the preparation of the drug prototype
- analyses of specificity of the action and toxicity of the virus
Publications and patents
Lab address
пр. Академика Лаврентьева, 8, Новосибирск, Новосибирская обл.
Authorization required.